¾ÅÉ«

Pharmiweb.com ¨C October 13, 2011

Canton, MI ¨C MMS Holdings Inc. announces a strategic alliance with ¾ÅÉ«, the world's largest privately held provider of language services and technology, to offer translation and interpretation services to their clients across global clinical programs. These services are complimentary to those offered at MMS, including statistical support, clinical programming, medical writing, pharmacovigilance, and regulatory submission services.

The partnership will provide MMS client teams with more flexibility and the option to have MMS coordinate the translation of all clinical documents, facilitating and expediting their global submission efforts. In addition, both companies will now be able to offer more streamlined solutions for pharmaceutical companies, with quality as the key driver.

"We are pleased to announce our alliance with MMS, a leading provider in the development space. Since their founding, MMS has provided their clients with optimal services and ¾ÅÉ« is excited to support their team with our language and technology solutions," said Michael Smyth, General Manager of Life Science ¾ÅÉ« at ¾ÅÉ«.

"MMS Holdings is committed to meeting the needs of our client sponsors and this partnership is a step toward this end, allowing sponsor teams to leverage the expertise of our staff and that of our partners," said Prasad Koppolu, Vice President for MMS Holdings Inc.

About MMS Holdings Inc.
MMS Holdings Inc. is headquartered in Canton, MI and is a highly experienced pharmaceutical service organization that is focused on quality deliverables in the areas of Clinical Programming, Biostatistics, Medical /Regulatory Writing and comprehensive Pharmacovigilance services. Commitment to quality deliverables with robust submission experience sets MMS apart from traditional service providers. MMS Holdings Inc. is ISO 9001 and ISO 27001 certified for all services and maintains detailed quality metrics for every project. For more information visit: .

About ¾ÅÉ« Life Sciences
¾ÅÉ« Life Sciences is the world's leading provider of language services and technology solutions to the life sciences industry. Supported by an ISO 9001:2008 and EN 15038:2006 certified quality management system, ¾ÅÉ« provides a full suite of services, including translation, linguistic validation, multicultural marketing, website localization, IVR solutions, and more. With advanced security and reporting capabilities, ¾ÅÉ«'s Trial Interactive e-clinical platform offers a streamlined solution for eTMF, endpoint adjudication, safety reporting, and other development processes. ¾ÅÉ« provides dedicated, local client service out of more than 70 cities on five continents. For more information, please visit our website at www.transperfect.com.